Physician profile
Benjamin G Coombs
NPI 1942641162
$5,862.48
in general payments reported to CMS, 2019-2025
17 companies · $1,263 in 2025
The $1,263 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $914 · 2020: $159 · 2021: $409 · 2022: $958 · 2023: $974 · 2024: $1,186 · 2025: $1,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,423.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,447.26 | 2021-2025 | Eluvia, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Jetstream Sc |
| Inari Medical, INC. | $738.92 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $717.62 | 2021-2025 | Abre, In.Pact Admiral, Mvp |
| Stryker Corporation | $703.82 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Optablate |
| Shockwave Medical, INC | $642.32 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $601.19 | 2019 | |
| Penumbra, INC. | $145.67 | 2022 | |
| Medtronic Vascular, INC. | $136.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $126.38 | 2019-2024 | Xarelto |
| Amgen INC. | $119.85 | 2022 | |
| Histosonics, INC. | $106.26 | 2024 | |
| Abbott Laboratories | $96.64 | 2025 | Esprit |
| Angiodynamics, INC. | $85.32 | 2023-2024 | Alphavac |
| Ethicon US, LLC | $75.90 | 2019 | |
| Bard Peripheral Vascular, INC. | $64.89 | 2024-2025 | Venovo, Fluency Endovascular Stent Graft, Pristine |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $29.67 | 2025 | Clonoseq |
| Inquis Medical, INC. | $23.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Coombs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.